UnitedHealth Group Inc (NYSE:UNH) has received an average recommendation of “Buy” from the twenty-eight analysts that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and twenty-five have given a buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $226.08.
A number of equities research analysts recently issued reports on the company. Goldman Sachs Group assumed coverage on UnitedHealth Group in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price objective on the stock. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 27th. Cantor Fitzgerald restated a “buy” rating and issued a $235.00 price objective on shares of UnitedHealth Group in a research note on Monday, December 25th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Finally, Raymond James Financial restated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 6th.
UnitedHealth Group (NYSE UNH) traded up $1.19 during midday trading on Monday, hitting $225.39. The stock had a trading volume of 2,543,363 shares, compared to its average volume of 2,682,745. The company has a market cap of $217,920.00, a PE ratio of 25.61, a price-to-earnings-growth ratio of 1.57 and a beta of 0.66. UnitedHealth Group has a 12 month low of $156.09 and a 12 month high of $231.77. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s payout ratio is presently 34.09%.
In other news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold a total of 34,630 shares of company stock valued at $7,669,416 in the last ninety days. Insiders own 0.89% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group in the 2nd quarter worth approximately $110,000. Bruderman Asset Management LLC bought a new stake in UnitedHealth Group in the 2nd quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its position in UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new stake in UnitedHealth Group in the 2nd quarter worth approximately $121,000. Finally, Acrospire Investment Management LLC lifted its position in UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after buying an additional 400 shares during the last quarter. 86.01% of the stock is owned by institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.